Nurse Practitioner, Family · Covington, LA
NPI
1700088788
Since 2007
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
1116 W 21st Ave.
Covington, LA, 70433
Phone (985) 892-3031
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$431K
1,876 prescriptions
Company payments, 2025
$3,590
From 28 companies
Medicare prescription drug claims, 2024
In 2024, the drug Pamela B Egan prescribed most often to Medicare patients was Progesterone (Progesterone, Micronized), with 411 prescriptions and refills. In total Pamela B Egan wrote 1,876 Medicare prescriptions that cost $431K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-04-11.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Progesterone Progesterone, Micronized | 411 | 1,023 | 130 | $18K |
| Levothyroxine Sodium Generic | 128 | 356 | 38 | $1,599 |
| Estradiol (Once Weekly) Estradiol | 106 | 207 | 35 | $10K |
| Mounjaro Tirzepatide | 106 | 114 | 20 | $116K |
| Estradiol (Twice Weekly) Estradiol | 99 | 186 | 31 | $11K |
| Liothyronine Sodium Generic | 98 | 249 | 27 | $4,513 |
| Armour Thyroid Thyroid,pork | 93 | 184 | 27 | $7,607 |
| Dotti Estradiol | 58 | 105 | 17 | $7,153 |
| Ozempic Semaglutide | 39 | 54 | Under 11 | $52K |
| Estradiol Generic | 38 | 67 | 13 | $5,871 |
| Trulicity Dulaglutide | 37 | 62 | Under 11 | $60K |
| Np Thyroid Thyroid,pork | 36 | 61 | 14 | $2,328 |
| Xyosted Testosterone Enanthate | 31 | 31 | Under 11 | $18K |
| Fluconazole Generic | 28 | 28 | 22 | $225 |
| Testosterone Cypionate Generic | 27 | 64 | 14 | $1,736 |
Brand drugs: 469 claims; generic drugs: 1,274 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Pamela B Egan $3,590 ($3,590 in general payments such as food, travel and fees) from 28 companies. The largest payer was ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) with $460.
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 9 | $460 |
| Abbvie Inc. ABBV | 7 | $330 |
| AstraZeneca Pharmaceuticals LP AZN | 6 | $322 |
| Novo Nordisk Inc NVO | 7 | $315 |
| Amgen Inc. AMGN | 2 | $232 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 4 | $160 |
| Edwards Lifesciences Corporation EW | 1 | $142 |
| Exact Sciences Corporation EXAS | 3 | $140 |
| Tolmar, Inc. | 6 | $131 |
| Abbott Laboratories ABT | 1 | $124 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.